Literature DB >> 8126189

Respiratory syncytial virus subgroup B dominance during one winter season between 1987 and 1992 in Vancouver, Canada.

E Thomas1, M J Margach, C Orvell, B Morrison, E Wilson.   

Abstract

A subgroup analysis of 613 specimens submitted to the British Columbia's Children's Hospital from 1987 to 1992 revealed that subgroups A and B of respiratory syncytial virus (RSV) were both circulating in our community, with some predominance for subgroup A during the period from October 1987 to September 1988 (the 1987-88 season) (64%), 1990-91 (60%), and 1991-92 (62%). During 1989-90 subgroup A represented the majority of isolates (80%). Subgroup B predominated during only one season, 1988-89 (94%). No microheterogeneity within subgroups was apparent as judged by the monoclonal antibody reactivity pattern. More male than female children were affected overall, but no sex-related difference between subgroup infections could be detected (P = 0.28). The majority of patients were less than 1 year of age, and no significant association between age and subgroup was detected after stratifying for year (P = 0.64). This is, to our knowledge, the first comprehensive longitudinal RSV subgroup prevalence study from the Pacific Northwest and from Canada.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8126189      PMCID: PMC263007          DOI: 10.1128/jcm.32.1.238-242.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Respiratory syncytial virus subgroups and pneumonia in children.

Authors:  J C Russi; H Chiparelli; A Montano; P Etorena; M Hortal
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

2.  The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.

Authors:  P R Johnson; M K Spriggs; R A Olmsted; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.

Authors:  L J Anderson; J C Hierholzer; C Tsou; R M Hendry; B F Fernie; Y Stone; K McIntosh
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

4.  Respiratory syncytial virus in a community population: circulation of subgroups A and B since 1965.

Authors:  A S Monto; S Ohmit
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

5.  Variation in severity of respiratory syncytial virus infections with subtype.

Authors:  K M McConnochie; C B Hall; E E Walsh; K J Roghmann
Journal:  J Pediatr       Date:  1990-07       Impact factor: 4.406

6.  Antigenic variation between human respiratory syncytial virus isolates.

Authors:  H B Gimenez; N Hardman; H M Keir; P Cash
Journal:  J Gen Virol       Date:  1986-05       Impact factor: 3.891

7.  Antigenic characterization of respiratory syncytial virus associated with acute respiratory infections in Uruguayan children from 1985 to 1987.

Authors:  J C Russi; A Delfraro; J R Arbiza; H Chiparelli; C Orvell; M Grandien; M Hortal
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

8.  Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections.

Authors:  M A Mufson; R B Belshe; C Orvell; E Norrby
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

9.  Monoclonal antibodies demonstrate heterogeneity in the G glycoprotein of prototype strains and clinical isolates of respiratory syncytial virus.

Authors:  G A Storch; C S Park
Journal:  J Med Virol       Date:  1987-08       Impact factor: 2.327

10.  Prevalence of respiratory syncytial virus subgroups over six consecutive outbreaks: 1981-1987.

Authors:  R M Hendry; L T Pierik; K McIntosh
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

View more
  3 in total

Review 1.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 2.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

3.  Predicting the hotspots of age-adjusted mortality rates of lower respiratory infection across the continental United States: Integration of GIS, spatial statistics and machine learning algorithms.

Authors:  Abolfazl Mollalo; Behrooz Vahedi; Shreejana Bhattarai; Laura C Hopkins; Swagata Banik; Behzad Vahedi
Journal:  Int J Med Inform       Date:  2020-08-22       Impact factor: 4.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.